Periodic Reporting for period 1 - DiogenX (Beta-cell recovery to counter diabetes)

Globally 20 M of T1D patients rely on exogenous insulin administration as the only treatment to manage their disease. The treatment is complex to follow since it requires not only to inject insulin (2-4 times/day) but to adhere to a restrictive lifestyle (e.g., following a...